Addressing advanced stakeholder needs in biologics: a case study on PFS and coated plunger
The use of biologics is a rapidly growing field in the treatment of chronic diseases, both in hospitals and through patient self-medication at home. Pharma companies' development pipelines for injectable biologics are well-filled, projecting a high demand for high-end container solutions. These solutions must be robust and reliable to address the numerous challenges of biologics, such as drug-container interactions, particles, and functional requirements.
In this joint Pharmaversity® session with Datwyler, we will explore how the syriQ BioPure® prefillable glass syringe (PFS) platform and the spray-coated NeoFlex™ plunger portfolio are addressing stakeholder needs in biologics - from pharmaceutical requirements to user needs and processability, including important topics like drug compatibility, device integration, supply chain security, sustainability, and the latest regulatory considerations.
In this joint Pharmaversity® session with Datwyler, we will explore how the syriQ BioPure® prefillable glass syringe (PFS) platform and the spray-coated NeoFlex™ plunger portfolio are addressing stakeholder needs in biologics - from pharmaceutical requirements to user needs and processability, including important topics like drug compatibility, device integration, supply chain security, sustainability, and the latest regulatory considerations.
